Intravenous Iron Drugs Usage in the Treatment of Iron Deficiency Anemia in Patients with Chronic Kidney Disease
DOI:
https://doi.org/10.22141/2307-1257.3.17.2016.76454Keywords:
intravenous iron supplementation, iron usage in anemia treatment at chronic kidney disease, Ferinject® fficacy in chronic kidney diseaseAbstract
The article reviews the current recommendations on treating anemia in chronic kidney disease. It is emphasized on the priority appointment of iron preparations. The comparative characteristic of iron supplementation efficacy in chronic renal diseas is presented. Advantages of ferric carboxymaltose are discussed.
Downloads
References
Ene-Iodache B., Perico N., Bikbov B et al. CKD and cardiovascular risk in six regions of the world (ISN-KDDC) // Lancet Glob Health. — 2016. — 4 (5). — e307-19.
Drawz P., Rahman M. In the clinic Chronic kidney disease // Ann. Intern. Med. — 2009. — 150. — ITC2-1–15. quiz ITC12-16.
Astor B.C., Muntner P., Levin A., Eustace J.A., Coresh J. Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988–1994) // Arch Intern. Med. — 2002. — 162. — 1401-1408.
Van Stralen K.J., Krischock L., Schaefer F., Verrina E., Groothoff J.W. et al. Prevalence and predictors of the sub-target Hb level in children on dialysis // Nephrol. Dial. Transplant. — 2012. — 27 (6). doi: 10.1093/ndt/gfs178.
Bauer С. Erythropoietin — from gene structure to therapeutic applications // J. Perinat. Med. — 1995. — 23. — 77-81.
Holland D.C., Lam M. Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study // Nephrol. Dial. Transplant. — 2000. — 15. — 650-658.
Levin A., Djurdjev O., Duncan J., Rosenbaum D., Werb R. Haemoglobin at time of referral prior to dialysis predicts survival: An association of haemoglobin with long-term outcomes // Nephrol. Dial. Transplant. — 2006. — 21. — 370-377.
Klang B., Bjorvell H., Clyne N. Quality of life in predialytic uremic patients // Qual. Life Res. — 1996. — 5. — 109-116.
Teehan B.P., Benz R.L., Sigler M.H., Brown J.M. Early intervention with recombinant human erythropoietin therapy // Semin. Nephrol. — 1990. — 10. — 28-34.
KDIGO (2012) [Kidney International Supplements (2012) 2, 281; doi:10.1038/kisup.2012.39].
Kidney Disease: Improving Global Outcomes guidelines on anaemiz management in chronic kidney disease: a European Renal Best Practoce position statement // Nephrol. Dial. Transplant. — 2013. — Vol. 28, № 6. — 1346-1359.
Anaemia management in people with chronic kidney disease // National Clinical Guideline Centre. Anaemia management in people with chronic kidney disease. — London (UK): National Institute for Health and Care Excellence (NICE), 2015 Jun 3. — 43 p. (NICE guideline; no. 8).
Shepshelovich D., Rozen-Zvi B., Avni T. et al. Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis // Am. J. Kidney Dis. — 2016 Jun 16. pii: S0272-6386(16)30125-1. doi: 10.1053/j.ajkd.2016.04.018.
Crichton R. et al. Iron Therapy With Special Emphasis on Intravenous Administration. — 4th edition. — London; Boston: International Medical Publishers, 2008.
Macdougall I.C., Bock A.H., Carrera F., Eckardt K.-U., Gaillard C. et al. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia // NDT. — 2014. — 29 (11). — 2075-2084. doi: 10.1093/ndt/gfu201
Moore R.A., Gaskell H., Rose P., Allan J. Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews, 2011.
Shepshelovich D., Rozen-Zvi B., Avni T. et al. Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis // Am. J. Kidney Dis. — 2016 Jun 16. pii: S0272-6386(16)30125-1. doi: 10.1053/j.ajkd.2016.04.018. (Review) PMID: 27321965
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 D.D. Ivanov, Ya.A. Dombrowski
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN 
ISSN 
